The structure of BRMS1 nuclear export signal and SNX6 interacting region reveals a hexamer formed by antiparallel coiled coils by Spínola-Amilibia, Mercedes et al.
1 
The structure of BRMS1 nuclear export signal and SNX6 interacting 
region reveals a hexamer formed by antiparallel coiled coils 
 
 Mercedes Spínola-Amilibia
1
, José Rivera
2
, Miguel Ortiz-Lombardía
3
, Antonio 
Romero
4
, José L. Neira
5, 6
, Jerónimo Bravo
1* 
 
1 
Instituto de Biomedicina de Valencia (IBV-CSIC), C/ Jaime Roig 11, 46010, Valencia, Spain. 
2
 Centro Nacional de Investigaciones Cardiovasculares Carlos III, C/ Melchor Fernández 
Almagro 3, 28029, Madrid, Spain. 
3
 Architecture et Fonction des Macromolécules Biologiques, UMR6098, CNRS, Universités 
d'Aix-Marseille I & II, Case 932, 163 Avenue de Luminy, 13288, Marseille cedex 9, France. 
4
 Departamento de Biología Físico-Química, Centro de Investigaciones Biológicas, CSIC, C/ 
Ramiro de Maeztu 9, 28040, Madrid, Spain. 
5
 Instituto de Biología Molecular y Celular, Universidad Miguel Hernández, Edificio 
Torregaitán, 03202, Elche, Spain. 
6
 Instituto de Biocomputación y Física de Sistemas Complejos, Mariano Esquillor, Edificio 
I+D, 50018, Zaragoza, Spain. 
  
Keywords: 
BRMS1, metastasis suppressors, coiled coil domain, X-Ray diffraction, Structure. 
 
* Corresponding author: 
Dept. of Genomics and Proteomics, Instituto de Biomedicina de Valencia (IBV-CSIC). C/ 
Jaime Roig 11. Valencia, Spain, 46010. Tel.: +34 96 339 1760; Fax: +34 96 369 0800. E-mail 
2 
address: jbravo@ibv.csic.es. 
 
Abbreviations used: BRMS1, Breast Cancer Metastasis Suppressor 1; SNX6, Sorting Nexin 
6; NES, Nuclear Export Signal; NLS, Nuclear Localization Signal; ARID4A, AT Rich 
Interactive Domain 4A; DOSY-NMR, Diffusion Ordered Spectroscopy-Nuclear Magnetic 
Resonance; DLS, Dynamic Light Scattering; D, translational diffusion coefficient; R, Stoke 
radius; c(s), sedimentation coefficient; TGN, Trans-Golgi Network; TGF-, Transforming 
Growth Factor beta; SMT3, small Ubiquitin-like modifier; ULP, SMT3 specific protease; 
GCN4, Aminoacid biosynthesis regulatory protein; TLS, Titration-Libration-Screw; r.m.s.d, 
root mean square deviation; PDB, Protein Data Bank.  
 
3 
ABSTRACT 
We present here the first structural report derived from Breast Cancer Metastasis 
Suppressor 1 (BRMS1), a member of the metastasis suppressor proteins group, which during 
recent years have drawn much attention since they suppress metastasis without affecting the 
growth of the primary tumour. The relevance of the predicted N-terminal coiled coil on the 
molecular recognition of some of the BRMS1 partners, on its cellular localization and on the 
role of BRMS1 biological functions such as transcriptional repression, prompted us to 
characterize its three-dimensional structure by X-Ray crystallography. 
The structure of BRMS1 N-terminal region, reveals that residues 51 to 98 form an 
antiparallel coiled coil motif, and also that it has the capability of homo-oligomerizing in a 
hexameric conformation, by forming a trimer of coiled coil dimers. We have also performed 
hydrodynamic experiments that strongly supported the prevalence in solution of this 
quaternary structure for BRMS151-98. 
This work explores the structural features of BRMS1 N-terminal region to help 
clarifying the role of this area in the context of the full-length protein. Our crystallographic 
and biophysical results suggest that the biological function of BRMS1 may be affected by its 
ability to promote molecular clustering through its N-terminal coiled coil region. 
 
INTRODUCTION 
Most human cancer deaths are caused by metastasis, a process involving several defined 
steps including detachment of cancer cells from a primary tumour, invasion of surrounding 
tissue, survival in the bloodstream, extravasation and colonization at distant organs. 
Many genetic events are required to promote metastasis including several genes that 
4 
show relative reduced expression levels in aggressive human tumours. Restoration of normal 
levels for some of these proteins in a metastatic tumour cell line results in a significant 
reduction of the metastatic behaviour in vivo with no effect on primary tumour growth
1
. Little 
is known about the molecular events triggered by this family of genes known as metastasis 
suppressors. Nevertheless, its function seems to become increasingly relevant towards the 
final stages of the metastatic cascade
2,3
. 
Breast cancer metastasis suppressor 1 (BRMS1), a member of this growing metastasis 
suppressor family, was identified by differential display and significantly reduced metastasis 
without affecting breast
4
, melanoma
5,6
 or ovarian carcinoma
7
 primary tumour growth.  
 BRMS1 transcriptional repression reduces metastasis and appears to be epigenetically 
regulated
8,9
. Molecular mechanisms of action for BRMS1 include restoration of cell-cell 
communication
10
 and abrogation of phosphoinositide signalling
11
. It has been proposed that 
BRMS1 might induce all these changes by playing a role in transcription
12-19
. In fact, BRMS1 
has the ability to form complexes with several proteins involved in the regulation of 
transcription
18,20,21
. Thus, BRMS1 can interact with a wide range of proteins in order to 
promote different effects in the metastatic cascade. Despite the wide biomedical interest, 
molecular characterization of BRMS1, including structural studies remains largely elusive. 
Analysis of the BRMS1 primary structure predicts a mostly disordered protein showing a few 
putative motifs, including two Nuclear Localization Signals (NLS) in two predicted coiled 
coil regions (Fig. 3d). 
 Coiled coil regions have long been known as protein-protein interaction modules that 
can exert biologically relevant functions
22,23
. In fact, BRMS1 second predicted coiled coil 
domain, including residues 130-187, is involved in interactions with ARID4A, part of the 
SIN3:histone deacetylase chromatin remodelling complex
18
. In addition, we have recently 
5 
shown that BRMS1 N-terminal putative coiled coil interacts with a predicted coiled coil 
region of SNX6 including residues 300-406, increasing BRMS1-dependent transcriptional 
repression
21
. Moreover, we have also shown that BRMS1 residues 74-91 have been identified 
as a functional Nuclear Export Signal (NES)
24
. Given that this predicted N-terminal coiled 
coil has an important role on the molecular recognition of some of the BRMS1 partners
18,21
, it 
contains a sequence essential for its cytoplasmic localization
24
, and that it has also been 
related to important BRMS1 biological functions such as transcriptional repression, we 
wanted to characterize its three-dimensional structure. We had previously reported the 
crystallization of BRMS1 including residues 51 to 84
25
 and now have solved the structure of 
the predicted BRMS1 coiled coil region including residues 51 to 98 (BRMS151-98). 
 Structural characterization of this BRMS1 fragment reveals a trimer of antiparallel 
binary coiled coils. The crystal structure is in agreement with the solution oligomerization 
state determined by analytical ultracentrifugation and hydrodynamic experiments. This 
particular molecular arrangement might suggest the ability of BRMS1 to promote molecular 
clustering through its N-terminal coiled coil region. 
 
RESULTS 
BRMS151-98 crystal structure 
 Human BRMS1 N-terminal coiled coil region (residues 51-98) was successfully 
expressed in Escherichia coli Rosetta(DE3)pLysS cells and purified by metal-chelating 
affinity chromatography followed by size-exclusion chromatography in a buffer containing 
20 mM TRIS-HCl pH 7.5 and 50 mM NaCl. The elution volume of BRMS151-98 in the pre-
calibrated gel filtration column corresponded to an apparent molecular weight of ~ 32 kDa 
6 
(data not shown). A major peak of protein, followed by absortion at 280 nm, was obtained at 
an elution volume of 160 mL. After analysis of more than 900 crystallization conditions and 
hit optimization, typical crystals grew with dimensions of 0.05 x 0.05 x 0.05 mm. Further 
improvement based mainly on the screening of different pH, precipitant concentration, 
temperature growing and protein:reservoir ratio volume, led to 0.25 x 0.25 x 0.25 mm 
crystals after three days. Prior to data collection, crystals (Fig. 1a) were vitrified in the 
presence of Paratone. 
 Diffraction data were collected and reduced to 1.9 Å. Data statistics of the X-ray 
diffraction experiments are shown in Table 1. Crystals are rhombohedral and belong to the 
R32 space group with unit-cell dimensions, in the hexagonal setting, a= 60.4 Å, b= 60.4 Å, 
c= 133.5 Å and = 90.0 º, = 90.0 º, = 120.0 º. 
 The asymmetric unit contains two BRMS151-98 molecules, chains A and B, arranged as 
a left-handed antiparallel coiled coil (Fig. 1b). Residues 95 to 98 and the initial serine derived 
from the cloning could not be located in the electron density maps. The final model includes 
residues E54 to G94 for chain A and E51 to L90 for chain B, 69 water molecules and a 
sulphate and two chloride ions (Table 1). All residues belong to the preferred regions in the 
Ramachandran diagram (refinement statistics obtained for the final model are summarized in 
Table 1). The solved structure contains five complete heptad repeats with a stutter prior to 
E76 (Fig. 1c), thus following a classical pattern of coiled coil motifs. The typical heptad 
repeat is defined in BRMS151-98 by residues E51, S58, L65, S72, E76, L83, and L90 in 
position a whereas residues E54, V61, E68, K75, F79, L86 and V93 would be occupying 
position d of their respective heptads (Fig. 1c). 
 The dimeric structure buries a total surface of 1,035 Å
2
 (calculated by PISA
26
) and is 
stabilized by hydrophobic interactions, mostly van der Waals contacts, with little polar and 
7 
electrostatic contribution. Notwithstanding, a salt bridge is established between the N atom 
of K75 from chain A and the Oe2 of E68 from chain B towards the coiled coil center (Fig. 2; 
Table 2). 
 The described coiled coil establishes additional interactions with symmetry-related 
super-coils. In order to establish whether the crystal shows any quaternary structure, an 
analysis of the possible interfaces, assemblies and surfaces was performed as implemented in 
PISA
26
. The antiparallel coiled coil establishes additional interactions with two symmetry-
related super-coils via the crystallographic 3-fold axis (Fig. 2). For convenience, chain A 
symmetry-related molecules have been named A' and A''. Similarly, chain B symmetry-
related molecules have been named B' and B''. 
 In the crystal, chain A interacts with chain B'' (Fig. 2a and 2d) in an antiparallel way, 
burying a total surface of 583 Å
2
. Salt bridges are established between E63 from chain A, and 
R82 from chain B'' and conversely between R82 in chain A and E63 in chain B''. An 
additional salt bridge is established between K75 in chain A and E68 in chain B'' (Fig. 2b and 
2d; Table 2). Chain A also interacts with chain A' (Fig. 2a) burying a total surface of 276 Å
2 
. 
Salt bridges are established between R57 in chain A and E59 or E63 in chain A' (Fig. 2c and 
2d; Table 2). A third distinct interacting surface is established between chain B and chain B' 
(Fig. 2a) burying a total surface of 321 Å
2
. This interface also shows the contribution of 
hydrogen bonds and salt bridges between E59 and E63 from chain B with R56 and R57 from 
chain B', respectively (Fig. 2d; Table 2). Finally, electrostatic interactions are also established 
between K75 from chains A' and A'' and E68 from chains B and B', respectively. These 
residues are located close to the crystallographic ternary axis (Fig. 2b). 
 In the resulting hexameric arrangement, the N-terminal regions of helices A, A' and A'' 
(residues 57 to 68) establish three-fold symmetric contacts. In turn, helices B, B' and B'' are 
8 
located, at these level, around the periphery of the hexameric ensemble, whereas at the other 
end of the haxamer their N-termini similarly form a three-fold symmetrical arrangement (Fig. 
2c and 2d). Overall, the hexamer buries a total surface area of 14,355 Å
2
. Around 42% of the 
total surface buried by the hexamer corresponds to interactions not directly involved in the 
formation of the antiparallel coiled coil. 
 In the hexamer, the thiol groups of C60 from chains A, A' and A'' are located within 
disulphide bond distance around the ternary axis. The same arrangement is found in chains B, 
B' and B''. Alternative conformers were clearly visible in the electron density maps (see 
discussion). 
 In summary, the X-Ray structure reveals a quaternary structure of a trimer of 
antiparallel coiled coils. This structural arrangement is in agreement with the results obtained 
from size-exclusion chromatography, where the apparent molecular weight of BRMS151-98 
was 32 kDa, i.e. approximately six times that of the monomer (5.9 kDa). To gather further 
evidence of this oligomeric state, we performed complementary biophysical studies. 
 
Hydrodynamic measurements 
 Hydrodynamic measurements of BRMS151-98 were performed in order to determine its 
translational diffusion coefficient (D) and the corresponding Stoke radius (R) using DLS and 
DOSY-NMR (Table 3). Furthermore, analytical ultracentrifugation was also carried out to 
determine the exact molecular weight of BRMS151-98. 
Dynamic Light Scattering 
 Using a solution of BRMS151-98 at 1 mg/mL (167 M), we obtained a maximum of 
intensity corresponding to a population with a 35 % of polidispersity, a hydrodynamic radius 
9 
of 2.6 nm and a molecular weight of 33 kDa (Fig. 3a). 
DOSY-NMR experiments 
 The D value of BRMS151-98 and the corresponding Stokes radius, R, are shown in 
Table 3; the values correspond to the average of three measurements. The theoretical ideal 
value of the hydrodynamic radius for an unsolvated spherical molecule, Rt, is given by: 
3 4N/3M πV=R Avt , where V  is the specific volume (0.70 cm
3
/g, which is the mean of the 
twenty aminoacids), NAv is Avogadro’s number and M is the molecular weight (5.9 kDa for 
monomeric BRMS151-98). That expression yields an R of 1.18 nm for BRMS151-98. This value 
is very different to that measured experimentally, suggesting that either the sample could 
correspond to a self-associating protein or alternatively, that the protein could be largely 
disordered. 
 Using an empirical function, we can estimate the expected R for monomeric 
BRMS151-98 to be between 1.47 nm, assuming that it is a folded protein (
0.020.291.114.75 ±)N±(=R , where N is the number of residues
27
) and 2.09 nm, if BRMS151-98 
behaves as a random-coil with disordered species ( 0.010.500.010.027 ±)M±(=R , where M is 
the molecular weight
28
). The experimental R of the BRMS151-98 species is larger than these 
theoretical boundaries, and therefore it does not adjust to a monomeric folded protein or to a 
monomeric unfolded protein. 
 As mentioned previously, C60 from different chains fall in close vicinity within the 
hexameric quaternary structure. Although the structure does not suggest the formation of 
disulphide bridges, the NMR analysis was also performed in the presence of 1 mM DTT (data 
not shown) obtaining similar results and therefore suggesting that disulphide bridges do not 
play a role in BRMS151-98 oligomerization state. 
10 
Analytical ultracentrifugation: Heterogeneity and sedimentation coefficient distributions of 
BRMS151-98 
 Size exclusion chromatography had shown that BRMS151-98 elutes as a 32 kDa protein 
on a Superdex 75 26/60 or Superdex 75 PC3.2/30 gel filtration columns using 20 mM TRIS-
HCl pH 7.5 and 50 mM NaCl buffer. Identical results were obtained along protein 
concentrations from 83.5 to 9 M, and also in the presence of 2 mM DTT (data not shown). 
The estimated molecular weight is in agreement with the hexameric quaternary structure 
found in the crystallographic structure of BRMS151-98. However, given that size-exclusion 
molecular weight estimations are not independent of molecular shapes, we decided to 
perform analytical ultracentrifugation analysis in order to further confirm the oligomeric state 
of BRMS151-98.  
 Sedimentation velocity experiments were carried out at 1, 0.5, 0.2, 0.1 and 0.05 
mg/mL that correspond to 167, 83.5, 33.4, 16.7 and 8.35 M respectively, to measure the rate 
at which BRMS151-98 molecules migrate in response to a centrifugal force. The c(s) profile of 
the protein obtained in the velocity experiment analysis (Fig. 3b) shows two peaks at 1 
mg/mL: a predominant component, at 93.1 %, with a sedimentation coefficient of 2.7 ± 0.1 S 
and a minor component (5.5 %) of 1.5 ± 0.1 S. The minor component was undetectable at 
lower concentrations, and the unique peak presented a sedimentation coefficient of 2.8 ± 0.1 
S (Fig. 3b). 
 Sedimentation equilibrium experiments (Fig. 3c) were also carried out in parallel to 
determine the molecular weight of BRMS151-98. Experimental data fitted with a model of 
single species and resulted in a molecular weight of around 34 kDa at a concentration of 167 
M and of 36 kDa in the concentration range of 0.5 to 0.05 mg/mL. The high quality of the 
fitting to the model is shown in Fig. 3c. 
11 
 
DISCUSSION 
BRMS151-98 is an antiparallel coiled coil motif 
 Despite its biological importance, structure-function studies on BRMS1 have 
remained elusive until now. Here we show that the BRMS151-98 fragment has structural 
integrity when isolated from the rest of the protein. The structure of the BRMS151-98 fragment 
shows a left-handed antiparallel coiled coil, with heptad-repeat positions a and d, which form 
the “knob into holes” packing typical of coiled coils, filled by seven polar residues and seven 
hydrophobic residues. Positions a and d are occupied by hydrophobic residues at the C-
terminus of the molecule, whereas positions e and g are mainly taken up by polar residues, 
being Arg the most representative aminoacid. These two characteristics, in addition to the 
stutter discontinuity that appears prior to E76 in BRMS151-98, are the most commonly 
observed consensus features described in coiled coil motifs
22,23
. The observed coiled coil 
extends at least between residues 51 and 94, which are clearly seen in the electron density 
maps and could be assigned to canonical heptad repeats (Fig. 1c). This observation further 
extends the lengthiest coiled coil assignment based solely on the sequence, which defined 
carboxylic end of the N-terminal coiled coil at residue 81 (Ncoils 1.0
29
, predicts a coiled coil 
between residues 49 and 81 with a probability higher than 0.8) (Fig. 3d). 
BRMS151-98 is a self-associating protein with potential to mediate oligomerization 
 Analysis of the interacting surfaces in the crystal structure shows that BRMS151-98 can 
self-associate in the absence of the rest of the protein, oligomerize as a homo-hexamer 
consisting of a trimer of antiparallel coiled coils (Fig. 2a). The oligomerization state of 
BRMS151-98 is not sustained by any di-sulphide bonds, since DOSY-NMR experiments gave 
12 
identical hydrodynamic results in the presence or in the absence of 1 mM DTT. Moreover, 
identical results were obtained in size exclusion chromatography in absence or presence of 2 
mM DTT indicating that no disulfide bridges are involved in oligomerization. The alternate 
conformations of C60 side-chains observed in the crystal are compatible with a static disorder 
resulting from different combinations of two C60 residues engaged in a disulphide bond and 
one free C60 residue. Consistent with the results obtained in solution, the dihedral angle 
around these bonds is only ~ 20 º, implying that they are very weak and easily reduced 
disulphide bonds. 
 The Stoke radius obtained from DLS and DOSY-NMR (2.6 nm and 2.52 nm, 
respectively) agrees remarkably well with the 2.7 nm calculated by HYDROPRO
30
 from the 
structure of the hexameric form of the BRMS151-98 fragment. In fact, we also used 
HYDROPRO to estimate the value of D from the hexameric structure, which produced a 
value of 7.99 x 10
-7
 cm
2
 s
-1
, very close to the experimentally determined 7.3 x 10
-7
 cm
2
 s
-1
 
and strongly supporting the idea that the hexamer observed in the crystal also exists in 
solution. 
 Analytical ultracentrifugation experiments allow the measurement of the molecular 
mass of a particle independently of its shape and also to perform protein association studies
31
. 
Both DLS and sedimentation velocity analytical ultracentrifugation showed that at a 
concentration of 167 M, BRMS151-98 is found in solution as two molecular species. Given 
that the molecular weight of monomeric human BRMS151-98 is 5.9 kDa and taking into 
account the frictional ratio calculated by SedFit software (~ 1.4), human BRMS151-98 behaves 
predominantly as a hexamer of around 39 kDa accounting for 93.1 % of the total mass, while 
a remaining 5.5 % of the mass shows a dimeric behavior (16 kDa). Subsequent experiments 
at 0.5, 0.2, 0.1 and 0.05 mg/mL only showed the hexameric signal (Fig. 3b), with an apparent 
13 
molecular weight of 36 kDa. Moreover, BRMS151-98 sedimentation equilibrium experimental 
data resulted in an average molecular mass of around 34 kDa and 36 kDa for 167 M and the 
83.5-8.35 M range respectively, in line with those determined by size-exclusion 
chromatography at the concentration range 83.5-9 M (32 kDa) and DLS at 167 M (33 
kDa). Finally, theoretical analysis of the interaction surfaces involved in the formation of the 
hexamer, performed with the PISA software
26
, suggests that this oligomer is the most stable 
quaternary structure in solution. Altogether, these results strongly support the notion that at a 
protein concentration as low as 0.05 mg/mL (8.35 M), BRMS151-98 already forms in solution 
the hexameric arrangement that we find in its crystal structure. 
 The closest structural similarity of BRMS151-98 is with the membrane-proximal 
ectodomain region of the envelope glycoprotein gp41 subunit from human immunodeficiency 
virus type 1 (PDB ID 3G9R), a transmembrane glycoprotein involved in the membrane-
fusion process of cellular and viral membranes that takes place during HIV-1 infection. 
Despite a sequence identity of only 5%, the alpha-carbon r.m.s.d. between BRMS151-98 and 
gp41 is 0.5 Å for 40 residues. The best overlap is with gp41 membrane proximal ectodomain 
region in a putative prefusion conformation
32
, however the postfusion state of gp41 including 
the inner core and outer layer of the gp41 ectodomain resembles that of BRMS151-98, since it 
is formed by a trimer of alpha-helical hairpins that plays a critical role in the membrane 
fusion of the virus
33
. There is however no conservation between the relative orientation of the 
helices in the two structures. 
Implications for BRMS1 cellular localization 
 At this stage, it is worth mentioning that the molecular weight of monomeric full-
length BRMS1 would allow passive diffusion of the protein through the channel of the 
14 
nuclear pore complex. However, BRMS1 contains a functional nuclear localization signal 
that interacts with importin 6. Furthermore, BRMS1 is also actively exported from the 
nucleus to the cytoplasm
24
. Indeed, we have previously identified a nuclear export signal 
involving BRMS1 residues 74 to 91, which partially overlaps with the C-terminal part of the 
coiled coil fragment BRMS151-98
24
 (Fig.3d). Three out of the four consensus hydrophobic 
residues for the nuclear export signal, are not accessible in the coiled coil and occupy 
positions a (L83) or d (F79 and L86) of the heptad repeat. This suggests that the coiled coil 
would require monomerization of the individual helices prior to its interaction with the 
nuclear exportins. Taken together, our findings suggest that BRMS1 might be part of a larger 
molecular entity with highly dynamic properties. Further experiments will be necessary to 
ascertain in vivo the existence and the composition of BRMS1 oligomers, which could, in 
principle, involve a BRMS1 hexamer built on the BRMS151-98 assembly that we have 
described. 
BRMS151-98 may establish molecular clusters 
 Coiled coil regions are well-known protein-protein interaction modules
22,23
. Our 
results confirm that BRMS151-98 is indeed a coiled coil region that could allow BRMS1 to 
establish homo- or hetero-oligomerization contacts. Actually, a number of proteins do interact 
with BRMS1 through their coiled coil motifs, e.g. ARID4A, which participates in the DNA 
remodelling complex Sin3-HDAC
18
, or the SNX6 protein
21
. In fact, residues 300-406 from 
SNX6 have been shown to interact with residues 1-88 from BRMS1
21
. Since this SNX6 
region includes a putative coiled coil, we anticipate that this is a coiled coil-mediated 
interaction. This interaction is of particular relevance since SNX6 is part of the retromer 
complex, involved in the transport of transmembrane cargo proteins from endosomes to the 
trans-Golgi network (TGN). Furthermore, SNX6 interacts with TGF- receptors, which have 
15 
largely been involved in metastasis. 
 The crystallographic quaternary structure of the BRMS151-98 fragment provides clues 
about the interaction of BRMS1 with other cellular partners through its N-terminal coiled 
coil, which we have proved to be longer than what was predicted from its sequence. Thus, 
this particular molecular arrangement might suggest the ability of BRMS1 to promote 
molecular clustering through its N-terminal coiled coil region. 
 A second region in the BRMS1 sequence is predicted to form a coiled coil around 
residues 147-180 that varies in length depending on the predictions tools used. In light of our 
observations the real coiled coil might extend further, specially if we take into account that 
the predictions are less favourable for this C-terminal coiled coil. Recent reports have shown 
that both coiled coil regions of BRMS1 are involved in hetero association with other proteins. 
However, we have also shown that, at least the N-terminal coiled coil is also capable of 
establishing homo oligomers. Additional studies should establish whether the second coiled 
coil is able to undergo a similar homooligomerization mechanism. 
 
CONCLUSION 
 The X-ray crystal structure that we report represents the first structural work on the 
human BRMS1 protein or any of its orthologs, opening new avenues to explore the function 
of this otherwise elusive protein. Together with the hydrodynamic data that we have gathered 
from a wide range of techniques, this structure shows that the predicted N-terminal coiled 
coil region of BRMS1 protein does actually form an antiparallel coiled coil motif with a 
capability of mediating oligomerization. Our observations suggest that BRMS1 biological 
function could be marked by an ability to establish molecular clusters. Alternatively, the N-
terminal coiled coil of BRMS1 protein, could be involved in more restricted oligomerization 
16 
in order to perform other biological functions, such as the modulation of transcription. 
Further efforts will test the validity of these hypotheses. 
 
MATERIALS AND METHODS 
Protein expression and purification 
 The DNA fragment encoding the first predicted coiled coil motif of human BRMS1 
including aminoacids 51-98 (BRMS151-98) was amplified from RZPD cDNA clone ID: 
IRALp962L0425Q2 by PCR using forward 
5´
GCG-ggatcc-GAGGACTATGAGCGACGCC
3´
 
and reverse 
5´
CGC-ctcgag-TTAGGCTCTCTCAGCCCC
3´ primers that contain restriction 
sites shown in lower case to facilitate the cloning. The amplicon was subcloned into a 
modified version of plasmid pET28 (Novagen) that allows the expression of an N-terminally 
6xHis/SMT3 fusion protein
34
. After cleavage with a SMT3 specific protease ULP, a serine 
residue is introduced at the N-terminus. The DNA sequence-verified construct was 
transformed into Rosetta(DE3)pLysS E. coli cells for His-SMT3-BRMS151-98 fusion protein 
expression. 
 Overproduction of the target protein was carried out at 310 K using 2xTY medium 
(Twice-concentrated Tryptone-Yeast extract; 16 g/L Tryptone, 10 g/L Yeast extract, 85 mM 
NaCl, pH 7.2). The expression was induced by addition of 1 mM Isopropyl β-D-1-
thiogalactopyranoside (IPTG) when the optical density at 600 nm reached a value of 0.7, and 
cells were harvested after 4 hours and resuspended in lysis buffer (50 mM TRIS-HCl pH 7.5, 
500 mM NaCl, 0.5 % Tween-20 and 0.2 mM AEBSF (4-(2-Aminoethyl) benzenesulfonyl 
fluoride hydrochloride; Sigma)). 
 After cell lysis by sonication and removal of cell debris by centrifugation (30 minutes 
17 
at 20,000 x g), the fusion protein was histidine-affinity purified using 5 mL Hi-Trap 
Chelating columns (GE Healthcare) previously loaded with Nickel Sulphate, washed with 50 
mM TRIS-HCl pH 7.5, 150 mM NaCl and 10 mM Imidazole and eluted with a linear gradient 
against 50 mM TRIS-HCl pH 7.5, 150 mM NaCl and 500 mM Imidazole. The SMT3 specific 
protease ULP was added to the eluate in a 1:1,000 concentration (protease weight:protein 
weight) and the mixture was dialysed overnight at 277 K, against 50 mM TRIS-HCl pH 7.5 
and 150 mM NaCl, using “Slide-A-Lyzer Dialysis Cassettes” of 3.5 kDa cut-off (Pierce). To 
remove the His/SMT3, the sample underwent a second histidine-affinity purification step. 
The flow-through fraction was loaded in a size-exclusion Superdex 75 26/60 column (GE 
Healthcare) equilibrated with 20 mM TRIS-HCl pH 7.5 and 50 mM NaCl, at 277 K. 
Fractions containing highly purified protein, as estimated by SDS-PAGE electrophoresis and 
Coomassie staining, were further concentrated with ultrafiltration devices (5 kDa cut-off, 
Millipore), flash cooled under liquid nitrogen and stored at 193 K until use. 
 
Structure determination 
Protein Crystallization and X-ray data collection 
 Initial crystallization trials were performed on a Cartesian Honeybee robot (Digilab) 
using commercial kits and various protein concentrations. After evaluation of initial hits, 
optimized crystals were obtained by the hanging-drop vapour diffusion method at 295 K. 
Briefly, 1 µL of purified BRMS151-98 protein at 50 mg/mL was mixed with 1 µL reservoir 
solution (0.1 M Sodium Citrate pH 5.25, 1.5 M Ammonium Sulphate) and equilibrated 
against 0.5 mL reservoir solution. Crystals were cryo-protected using paratone-N (Hampton 
Research), mounted on cryo-loops and flashed-cooled at 100 K under a cryogenic nitrogen 
stream. The diffraction data (Table 1) were collected on the ID14eh4 beamline at the ESRF 
18 
(Grenoble, France) at a wavelength of 1.2785 Å and using a Q315r ADSC X-ray detector. 
The images were collected using the beamline software MXCuBE (“MX Customised 
Beamline Environment”). 
 Data reduction was performed using MOSFLM for reflection, indexing and 
integration and SCALA for scaling and merging, both from the CCP4 program suite
35
. 
Structure determination and refinement 
 The 3D structure of BRMS151-98 was solved by automated search with Phaser
36
 using 
coordinates from PDB ID 2CCF as a molecular replacement model. This model refers to 
residues 249-281 of the yeast transcriptional activator GCN4 and includes two chains with 31 
residues modelled in chain A and 32 residues in chain B
37
. The search of a good rotation and 
translation solution was carried out by defining two individual ensembles, one containing the 
chain A and the second one with the chain B, and looking for one copy from each. The 
resulting model was modified and completed manually in the real space by Coot
38
, with 
alternating refinement cycles in the reciprocal space using Refmac5
39
 with TLS
40
 and Babinet 
scaling. The TLS groups were selected using the internet web tool TLSMD
41
.  
 Real-space correlation, coordinate errors, R, Rfree, B factors and r.m.s.d. were checked 
using Sfcheck, Procheck
42
 and Baverage (CCP4
35
). Molprobity
43 
together with Monster
44
 and 
Contact (from CCP4
35
) were used for the geometric and contact analyses, and AreaIMol 
(CCP4 package
35
) and PISA software
26
 to explore macromolecular interfaces and assemblies. 
 
Dynamic Light Scattering 
 Dynamic Light Scattering (DLS) measurements to obtain hydrodynamic radii of 
BRMS151-98 protein were carried out at 293 K with a DynaPro
TM
 instrument (Protein 
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Solutions), using a quartz cuvette of 3 mm path length. Protein samples (1 mg/mL) in 20 mM 
TRIS-HCl pH 7.5 and 50 mM NaCl, were centrifuged for 10 minutes at 16,000 x g prior to 
measurements. Thirty readings were collected with 5 seconds acquisition time and a 100 % of 
incident beam power. The data were visualized and analysed using the Dynamics V6 software 
to obtain the hydrodynamic radius of the particles, the apparent molecular size and the 
homogeneity of the sample. 
 
DOSY-NMR experiments 
 The NMR experiments were acquired on an Avance DRX-500 spectrometer (Bruker 
GmbH, Karlsruhe, Germany) equipped with a triple resonance probe and z-pulse field 
gradients. 
 NMR samples for DOSY-NMR spectra were prepared by concentrating the samples in 
Centriprep devices (5 kDa cut-off, Millipore) in a H2O:D2O (1:9) solution. The solution was 
centrifuged briefly to remove insoluble protein and then transferred to a 5 mm NMR tube at 
293 K. Final protein concentrations of BRMS151-98 were in the range 100-150 M. The pH of 
the sample was 6.9 (50 mM sodium phosphate buffer). Values of the pH reported here 
represent apparent values of pH, without correction for isotope effects. TSP (3-
(trimethylsilyl)propionic-2,2,3,3-d4) was used as the internal chemical shift reference. 
 Translational self-diffusion measurements were performed with the pulsed-gradient 
spin-echo sequence. The following relationship exists between the translational self-diffusion 
parameter, D, and the delays during acquisition
45
: 













23
exp 222
0
τδ
ΔGδDγ=
I
I
H   
where I is the measured peak intensity of a particular (or a group of) resonance(s); I0 is the 
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maximum peak intensity of the same resonance(s) at the smaller gradient strength; D is the 
translational self-diffusion constant (in cm
2
 s
-1
);  is the duration (in s) of the gradient; G is 
the gradient strength (in T cm
-1
);  is the time (in s) between the gradients; H is the 
gyromagnetic constant of the proton; and  is the recovery delay between the bipolar 
gradients (100 s). Data are plotted as I/I0 versus G
2 
and the exponential factor of the 
resulting curve is 






23
22 τδΔδDγH , from where D can be easily obtained. The duration of 
the gradient was varied between 2.6 and 3 ms, and the time between both gradients was 150 
ms. The most up-field shifted methyl groups (those between 0.5 and 1 ppm) were used to 
measure the intensity changes. 
 The value of the Stokes radius, R, was determined as described by Dobson and co-
workers
27
. Briefly, a 0.1 % of dioxane was added to the BRMS151-98 sample, and its D was 
calculated. Since the R of dioxane is 2.12 Å, the R of the protein can be obtained. 
 
Analytical ultracentrifugation 
 The sample protein at 1, 0.5, 0.2, 0.1 and 0.05 mg/mL (corresponding to 167, 83.5, 
33.4, 16.7 and 8.35 M respectively) in buffer containing 20 mM TRIS-HCl pH 7.5 and 50 
mM NaCl were pre-cleared at 16,000 x g before ultracentrifugation protocol. The analytical 
ultracentrifugation experiments were conducted at 293 K. 
Velocity measurements 
 Sedimentation velocity experiment was performed on an Optima XL-I (Beckman, 
CA), using an AnTi50 rotor and a standard double-sector Epon-charcoal center pieces (1.2 cm 
optical path length). 400 L of sample and reference solution were loaded and sedimented at 
21 
48,000 rpm during 3 hours and 30 minutes, registering successive entries every minute. The 
evolution of the resulting concentration gradient of material in the cell as a function of time 
and radial position was monitored using Rayleigh interferometric detection in the case of the 
sample at 1 mg/mL and by absorbance at the wavelength 230 nm in the rest of the samples 
(0.5-0.05 mg/mL range). 
 Differential sedimentation coefficient distributions (c(s)) were calculated by least-
squares boundary modelling of sedimentation velocity data using SedFit software (Version 
11.8) as described
46
. The calculated frictional ratios were used to transform the c(s) 
distribution into the corresponding molar mass distribution
47,48
. 
Sedimentation Equilibrium 
 An Optima XL-A (Beckman, CA) analytical ultracentrifuge equipped with UV-visible 
absorbance optics was employed for analytical ultracentrifugation measurements by using an 
An50Ti rotor. Short column (85 L) sedimentation equilibrium runs were carried out at 
multiple speeds (14.5, 19, and 28 krpm in the 1 mg/mL sample and 16, 19 and 22 krpm in the 
0.5-0.05 mg/mL range) by taking absorbance scans at the wavelength 280 nm (for 1 mg/mL) 
and 240-230 nm (for 0.5-0.05 mg/mL range). After the equilibrium scans, a high-speed 
centrifugation run at 45 krpm was done to estimate the corresponding baseline offsets. 
 The weight-average buoyant molecular weight of BRMS151-98 was calculated using 
the Hetero-Analysis program (Version 1.1.33)
49
. The molecular weight of the protein was 
determined from the experimental buoyant masses using the values of 0.7255 cm
3
/g and 
1.00087 g/cm
3
 as the partial specific volume and density, respectively. 
 
PDB accession numbers 
22 
 Coordinates and structure factors have been deposited in the Protein Data Bank with 
accession number 2XUS. 
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FIGURES: 
Figure 1: BRMS151-98 is an antiparallel coiled coil. 
(a) Crystal of BRMS1 amino terminal region (residues 51-98) obtained by the hanging-drop vapour-diffusion 
technique. The crystal was grown using 0.1 M Sodium Citrate pH 5.25 and 1.5 M Ammonium Sulphate in the 
reservoir. The approximate dimensions of the crystal were 0.25 x 0.25 x 0.25 mm. 
(b) Antiparallel coiled coil of amino terminal BRMS1 region (residues 51-98). The structure was solved by 
molecular replacement, using the program Phaser
36
 (from CCP4) and the 2CCF PDB ID model. The 
asymmetric unit contains two chains (A and B), which are represented in green (chain A) and in blue (chain B). 
Amino and carboxylic termini are shown as “N” and “C” respectively. Center and right images, generated upon 
rotation around x and y axis from the left image, show the twisting of the two antiparallel chains. 
(c) Heptad repeat assignment of BRMS151-98 established manually. Heptads, with repetition pattern from a to g, 
are delimited with boxes. Residues 51 to 94 of BRMS1 protein are numbered on the top of the assignment and 
identified with their corresponding letter in the heptad, where the critical positions a and d, mainly occupied by 
hydrophobic aminoacids, are shown in red. There is a discontinuity or stutter in the heptad pattern localized 
prior to E76, which is shown with an asterisk.  
 
Figure 2: The BRMS151-98 hexamer. 
(a) Cartoon representation of BRMS151-98 quaternary structure formed by a trimer of antiparallel coiled coils 
packed around a ternary axis. This hexamer is built by the interaction of the two chains of the asymmetric unit 
with four of their symmetry-related molecules. Chains are labelled as A (Chain A) and B (Chain B). Labels A' 
and A'', and B' and B'' refers to symmetry-related chains A and B respectively. The two molecules of each coiled 
coil are represented with the same colour: light brown for A-B; pink for A'-B' and blue for A''-B''. Carboxylic 
and amino terminals are shown as C and N respectively. Chloride and sulphate ions are represented as spheres 
and sticks respectively. 
(b) Detail of salt bridges established between K75 from chain A and symmetry-related chains A (A' and A'') and 
E68 from chain B and symmetry-related chains B (B' and B''), around the ternary axis. Distances between Oe2 
atom of E68 and N atom of K75 are represented as colour-coded lines as follows: 3.56 Å distance in red and 
3.07 Å in blue. 
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(c) Detail of the N-terminal salt bridges within symmetry-related chain groups A-A'-A'' (on the left) and B-B'-B'' 
(on the right). N abbreviation represents the amino termini. The hydrogen bonds (with distances shown in 
Angströms) between nitrogen and oxygen atoms of arginines and glutamic acids respectively, are represented 
with dotted lines. 
(d) Interacting surfaces among the different chains (A and B, in light brown) and symmetry-related molecules 
(pink and blue colours) established within the hexameric conformation. Each panel contains a distinct contact 
surface, concretely from pairs A-A'; B-B'; A-B and A-B'' (which are also detailed in Table 2). One molecule is 
represented as a ribbon cartoon and the other one as a molecular surface. The interacting residues are marked in 
dark brown in both chains. N and C letters indicate the amino and carboxylic ends of the molecule. A different 
orientation of the hexamer, resulting from a 90 º rotation in the y axis with respect to panel a, is shown in the 
centre. 
 
Figura 3. Hydrodynamic measurements in BRMS151-98 and schematic representation of structure motifs of the 
BRMS1 full length protein. 
(a) Dynamic Light Scattering of BRMS151-98 at 167 M of protein concentration, in a buffer containing 20 mM 
TRIS-HCl pH 7.5 and 50 mM NaCl and at 293 K. The highest peak of intensity corresponds to a hydrodynamic 
radius of 2.6 nm with a polidispersity of 35 % and an apparent molecular weight of 33 kDa. 
(b) Sedimentation velocity data for BRMS151-98 at 167 M (1 mg/mL); 83.5 M (0.5 mg/mL); 33.4 M (0.2 
mg/mL); 16.7 M (0.1 mg/mL) and 8.35 M (0.05 mg/mL), monitored using Rayleigh interferometric detection 
(1 mg/mL sample) and by absorbance at the wavelength 230 nm (the rest of samples). The experiment was 
carried out at 293 K; 48,000 rpm and in 20 mM TRIS-HCl pH 7.5 and 50 mM NaCl. Differential coefficient 
distribution (c(s)) was fitted using SedFit software
46
. The c(s) curve suggests that BRMS151-98 at 1 mg/mL 
present a predominant species (peak A) in a 93.1 % with a sedimentation coefficient of 2.7 ± 0.1 Svedberg and 
a second peak (B, 5.5 %) with 1.5 ± 0.1 S, and the range from 0.5 mg/mL to 0.05 mg/mL protein sample show 
an unique peak of 2.8 ± 0.1 S. The apparent molecular weights (16 kDa and 39 kDa for peaks B and A 
respectively at 1 mg/mL and 36 kDa for the unique peak at 0.5-0.05 mg/mL range) were calculated from the c(s) 
distribution, with a frictional ratio of 1.4. 
(c) Equilibrium sedimentation assay for BRMS151-98 sample at 167 M, was conducted at 293 K and with scan 
25 
data acquisition at 280 nm and at 14.5; 19 and 28 krpm of velocity. The residuals (lower panel) show the fitting 
between the experimental data and an ideal single-species model (blue line). 
(d) The aminoacid boundaries identified by different prediction servers as Disopred
50
, Porter
51
, DisEMBL
52
 or 
Poodle
53
 for unfolded regions, Paracoil
54
, Multicoil
55
, Coils
29
 for coiled coil motifs or Scansite
56
, PSORT II
57
 
and HPRD
58
 for phosphorilation sites, Retention and Nuclear Localization Signals
4
 are shown with numbers. It 
is shown two predicted imperfect Leucine zipper motifs. Blue, green, yellow and grey boxes show Glutamic 
Rich Region (E-Rich), functional Nuclear Export Signal (NES)
24
, functional Nuclear Localization Signal 
(NLS1)
24
 and predicted Nuclear Localization Signal (NLS2) respectively. The rhombi represent putative 
phosphorilation sites: red for Casein kinase II, brown for cAM/cGMP and grey for protein kinase C. The green 
rhombus at the C-terminal corresponds to an endoplasmic reticulum retention signal. The experimentally 
determined first coiled coil motif (from 51 to 98 residues) and the second predicted coiled coil are represented 
as orange and grey helices respectively. The predicted unfolded regions with their corresponding boundaries are 
shown as archway over the scheme. 
 
TABLES: 
Table 1. Data collection and refinement statistics for BRMS151-98 structure 
a
 Rmeas = {Σhkl [N/(N-1)]
1/2
 Σi |Ii(hkl) - <I(hkl)>|} / Σhkl Σi Ii(hkl), where Ii(hkl) are the observed intensities, 
<I(hkl)> are the average intensities and N is the multiplicity of reflection hkl. 
b
 Mean [I/(I)] is the average of the relation between the intensity of the diffraction and the background. 
c
 Rfactor = hkl {[Fobs(hkl)] - [Fcalc(hkl)]} / hkl [Fobs(hkl)], where Fobs(hkl) and Fcalc(hkl) are the structure factors 
observed and calculated, respectively. 
d
 Rfree corresponds to Rfactor calculated using 5 % of the total reflections selected randomly and excluded during 
refinement. 
e
 R.m.s.d. is the root mean square deviation. 
 
Table 2. Contacts and interfaces within the hexamer 
26 
Interfaces, hydrogen bonds and salt bridges established between chains A and B of the asymmetric unit and 
symmetry-related chains ( ' and '' ). The contacting atom from each residue is shown with brackets, and as “Dist” 
the distance between them. These analyses were carried out with Contact (from CCP4 suite
35
) and PISA
26
 
softwares. 
 
Table 3. Hydrodynamic measurements of BRMS151-98 species 
a 
Calculated by the mathematical expression of Dobson and co-workers assuming that BRMS151-98 species are 
monomeric folded proteins
27
. 
b 
Calculated by the mathematical expression of Gräslund and co-workers assuming that BRMS151-98 species are 
monomeric unfolded proteins
28
.
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